Examination of the treatment prediction factor of Ledipasvir/Sofosbuvir in chronic hepatitis C of Genotype1b.

Not Applicable

• Conditions: Chronic hepatitis C

• Registration Number: JPRN-UMIN000027860
• Lead Sponsor: ippon Medical School Chiba Hokusoh Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-06-22
• Study Completion: 2020-03-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 700

Inclusion Criteria

Not provided

Exclusion Criteria

Patient who did not obtain consent to use the data.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sustained virological response rate

Secondary Outcome Measures

Name	Time	Method
1. Change in serum HCV RNA during treatment and follow-up duration 2. Change in hematological and biochemical test during treatment and follow-up duration 3. Change in Mac-2 Binding Protein,hyaluronic acid, type IV collagen,gamma globulin during treatment and follow-up duration.